Skip to main content
. 2022 Jan 27;10(2):292. doi: 10.3390/biomedicines10020292

Figure 4.

Figure 4

(A) From an immunotherapy trial dataset (GSE121810), the ratio of M1/M2 macrophage and the mean value of RSI in neoadjuvant and adjuvant arm are compared. p-value was estimated with analysis of variance. (B) From the Glioma Longitudinal Analysis Consortium (GLASS), overall survival for recurrent glioblastoma population is compared, stratified by M2 macrophage and RSI status. p-value was estimated by log-rank test. (C) Comparison of overall survival between M2 macrophage-low and RSI-low group versus other population in recurrent glioblastoma. Abbreviations: M1, M1 macrophage; M2, M2 macrophage; RSI, radiosensitive index.